Cellyan Biotechnology (HKPD) Inventory Average (2024 - 2026)
Cellyan Biotechnology (HKPD) posted quarterly Inventory Average of $576677.5 for Q3 2025, down 22.53% year-over-year from $744410.5 in Q3 2024, and up 3.39% quarter-over-quarter from $557752.0 in Q1 2025.
Cellyan Biotechnology (HKPD) Inventory Average (2024 - 2026) Analysis & Trends
Cellyan Biotechnology (HKPD) has reported Inventory Average for 2 consecutive years, with $576677.5 the latest figure, recorded in Q3 2025.
- In Q3 2025, Inventory Average fell 22.53% year-over-year to $576677.5; the TTM figure through Sep 2025 stood at $576677.5 (down 22.53% YoY), while the FY2025 annual figure was $746640.5, changed N/A from the prior year.
- Inventory Average grew to $576677.5 in Q3 2025 per HKPD's latest filing, from $557752.0 in the prior quarter.
- Across five years, Inventory Average topped out at $744410.5 in Q3 2024 and bottomed at $557752.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.31 Bn | 97.15 Bn | 3.69 Bn | 25.23 Bn |
| 2 | Cencora | 61.60 Bn | 58.78 Bn | 3.61 Bn | 20.52 Bn |
| 3 | Cardinal Health | 54.09 Bn | 49.23 Bn | 2.56 Bn | 17.65 Bn |
| 4 | Henry Schein | 10.06 Bn | 9.90 Bn | 1.10 Bn | 2.04 Bn |
| 5 | Akso Health | 657.66 Mn | 657.46 Mn | - | 6.22 Mn |
| 6 | Edap Tms | 156.49 Mn | 134.95 Mn | 7.34 Mn | 11.77 Mn |
| 7 | Accendra Health | 92.03 Mn | 84.38 Mn | 263.41 Mn | 69.32 Mn |
| 8 | 111 | 30.17 Mn | -28.59 Mn | 18.18 Mn | 144.07 Mn |
| 9 | Cosmos Health | 13.14 Mn | 10.69 Mn | 1.51 Mn | 5.08 Mn |
| 10 | Cellyan Biotechnology | 6.61 Mn | 6.38 Mn | - | 476,740.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 476,740.00 |
| Sep 30, 2025 | 576,677.50 |
| Mar 31, 2025 | 557,752.00 |
| Sep 30, 2024 | 744,410.50 |